BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients.

Çeçener G., Egeli Ü., Tunca B., Ertürk E., Ak S., Gokgoz S., ...Daha Fazla

Cancer investigation, cilt.32, sa.8, ss.375-87, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 8
  • Basım Tarihi: 2014
  • Doi Numarası: 10.3109/07357907.2014.919302
  • Dergi Adı: Cancer investigation
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.375-87
  • Anahtar Kelimeler: Breast cancer, BRCA1/BRCA2 gene, A-GVGD, HSF, BRCAPRO, AND/OR OVARIAN-CANCER, FOUNDER MUTATIONS, GENE-MUTATIONS, FAMILIES, WOMEN, POPULATION, FREQUENCY, 185DELAG, PENETRANCE, PREVALENCE
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

BRCA1/BRCA2 genes were screened in 117 patients with breast cancer by sequencing. Fourteen percent of patients tested positive for BRCA1/BRCA2 mutations. Four frame shift mutations, four pathogenic missense mutations, and 25 different sequence variations were detected. BRCA mutation positivity was significantly associated with Ki67 (p =.001). BRCA protein expressions were decreased in the patients harboring important mutations and polymorphisms (BRCA1; P508stop, V1740G, Q1182R, Q1756P and BRCA2; V2466A) related with disease. Our findings contribute significantly to the types of germline BRCA1/BRCA2 mutations and their biological effects in Turkish women. These data could help guide the management of BRCA1/BRCA2 mutation-carrying patients when considering breast-conserving therapy.